Contact DMCA Privacy

Robuta

https://www.dana-farber.org/clinical-trials/19-221
A Multinational, Multicenter, Phase 2 Study of Tesetaxel plus a Reduced Dose of Capecitabine in...
CONTESSA 2 is a multinational, multicenter, Phase 2 study of tesetaxel in patients with HER2 negative, HR positive, locally advanced or metastatic breast...
multinationalphasestudytesetaxelplus